Intranasal Vaccine
Showing 1 - 25 of 9,219
COVID-19 Trial (CVXGA1)
Not yet recruiting
- COVID-19
- CVXGA1
- (no location specified)
Feb 17, 2023
Covid19 Trial in Lenexa, Raleigh (Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal
Recruiting
- Covid19
- Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal Drops
- +4 more
-
Lenexa, Kansas
- +1 more
Aug 1, 2022
Corona Virus Infection Trial in India (COVAXIN(BBV152), BBV154 Intranasal Vaccine)
Completed
- Corona Virus Infection
- COVAXIN(BBV152)
- BBV154 Intranasal Vaccine
-
New Delhi, Delhi, India
- +10 more
Nov 25, 2022
Respiratory Syncytial Virus (RSV) Trial in United States (Investigational RSV vaccine MV-012-968 (Dosage 1), Investigational RSV
Recruiting
- Respiratory Syncytial Virus (RSV)
- Investigational RSV vaccine MV-012-968 (Dosage 1)
- +5 more
-
Phoenix, Arizona
- +11 more
Aug 1, 2022
Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)
Not yet recruiting
- Healthy
- H107e
- +10 more
-
Pretoria, Gauteng, South AfricaAurum Institute
Sep 24, 2023
Tuberculosis Infection Trial in Saint Petersburg (TB/Flu-05E vaccine, Placebo)
Active, not recruiting
- Tuberculosis Infection
- TB/Flu-05E vaccine
- Placebo
-
Saint Petersburg, Russian FederationSmorodintsev Research Institute of Influenza
Jul 11, 2023
COVID-19 Respiratory Infection Trial in India (BBV154 Intranasal Vaccine, Intramuscular vaccine COVAXIN, Covishield)
Completed
- COVID-19 Respiratory Infection
- BBV154 Intranasal Vaccine
- +2 more
-
Patna, Bihar, India
- +8 more
Oct 1, 2022
Coronavirus Trial in Oxford (ChAdOx1 nCov-19)
Completed
- Coronavirus
- ChAdOx1 nCov-19
-
Oxford, United KingdomCCVTM, University of Oxford, Churchill Hospital
Oct 21, 2022
SARS-CoV Infection Trial in India (BBV154 Vaccine, Placebo)
Completed
- SARS-CoV Infection
- BBV154 Vaccine
- Placebo
-
Patna, Bihar, India
- +3 more
Aug 17, 2022
Bordetella Pertussis, Whooping Cough Trial in United Kingdom (BPZE1 pertussis vaccine and , BPZE1 pertussis vaccine and
Recruiting
- Bordetella Pertussis, Whooping Cough
- BPZE1 pertussis vaccine and placebo
- +2 more
-
Randwick, New South Wales, Australia
- +15 more
Oct 20, 2022
Covid19 Trial in United States (CVXGA1 low dose, CVXGA1 high dose)
Recruiting
- Covid19
- CVXGA1 low dose
- CVXGA1 high dose
-
Bardstown, Kentucky
- +3 more
Aug 16, 2022
Influenza, Pandemic Trial in Baltimore (BW-1014: 25 µg rH5 in 20% NE - pipette - IN, BW-1014: 50 µg rH5 in 20% NE - pipette -
Recruiting
- Influenza, Pandemic
- BW-1014: 25 µg rH5 in 20% NE - pipette - IN
- +5 more
-
Baltimore, MarylandCenter for Vaccine Development and Global Health, University of
Jul 8, 2022
COVID-19 Trial in Saint Petersburg (Corfluvec component 1 low dose, Corfluvec component 2 low dose, Corfluvec component 1 high
Active, not recruiting
- COVID-19
- Corfluvec component 1 low dose
- +6 more
-
Saint Petersburg, Russian Federation
- +1 more
Jan 23, 2023
Respiratory Syncytial Virus Infections Trial in Norfolk, Omaha, Cincinnati (Investigational RSV vaccine MV-012-968 (Dosage 1),
Completed
- Respiratory Syncytial Virus Infections
- Investigational RSV vaccine MV-012-968 (Dosage 1)
- +3 more
-
Norfolk, Nebraska
- +2 more
Jun 26, 2021
Pertussis, Pertussis Immunisation Trial in Nashville (BPZE1, Placebo)
Completed
- Pertussis
- Pertussis Immunisation
- BPZE1
- Placebo
-
Nashville, TennesseeVanderbilt University - Pediatric - Vanderbilt Vaccine Research
Jan 6, 2022
COVID-19 Trial in Sippy Downs (biological, combination product, other)
Not yet recruiting
- COVID-19
- Avacc 10
- +2 more
-
Sippy Downs, Queensland, AustraliaUniversity of the Sunshine Coast Clinical Trial Centre
Nov 1, 2022
SARS-CoV-2 Infection Trial in Mexico City (Recombinant NDV Vectored Vaccine for SARS-CoV-2)
Completed
- SARS-CoV-2 Infection
- Recombinant NDV Vectored Vaccine for SARS-CoV-2
-
Mexico City, Ciudad De Mexico, MexicoHospital Medica Sur
Dec 8, 2022
Anthrax Trial in Lenexa (BW-1010: 50 µg - sprayer - IN, BW-1010: 50 µg - pipette - IN, BW-1010: 100 µg - sprayer - IN)
Completed
- Anthrax
- BW-1010: 50 µg - sprayer - IN
- +6 more
-
Lenexa, KansasJohnson County Clin-Trial
May 12, 2022
Influenza, Vaccine Virus Shedding Trial in London (Live attenuated influenza vaccine, Vehicle control)
Completed
- Influenza
- Vaccine Virus Shedding
- Live attenuated influenza vaccine
- Vehicle control
-
London, United KingdomImperial Clinical Respiratory Research Unit
Nov 1, 2021
Covid19 Trial in Brisbane (SC-Ad6-1)
Recruiting
- Covid19
- SC-Ad6-1
-
Brisbane, Queensland, AustraliaTetherex Study Site
Apr 29, 2022
Pertussis/Whooping Cough, Bordetella Pertussis, Whooping Cough Trial in Southampton (biological, drug, other)
Recruiting
- Pertussis/Whooping Cough
- Bordetella Pertussis, Whooping Cough
- BPZE1
- +3 more
-
Southampton, United KingdomUniversity Hospital Southampton
Jul 19, 2022
SARS CoV 2 Infection Trial in Mexico City (Recombinant NDV Vectored Vaccine for SARS-CoV-2, Placebo)
Recruiting
- SARS CoV 2 Infection
- Recombinant NDV Vectored Vaccine for SARS-CoV-2
- Placebo
-
Mexico City, Cdmx, Mexico
- +3 more
Mar 23, 2022
Influenza Trial in Stanford (2008-2009 FluMist LAIV (Intranasal))
Terminated
- Influenza
- 2008-2009 FluMist LAIV (Intranasal)
-
Stanford, CaliforniaStanford University School of Medicine
Sep 21, 2021
SARS-CoV-2 Trial in New York (Sodium Chloride, NDV-HXP-S IN low dose, NDV-HXP-S IM low dose)
Recruiting
- SARS-CoV-2
- Sodium Chloride
- +4 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jun 30, 2022
SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)
Recruiting
- SARS-CoV-2 Infection
- B/HPIV3/S-6P
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Aug 30, 2023